Clinical characteristics and outcomes of patients with Mycobacterium avium complex lung disease positive for Aspergillus precipitating antibody

T. Shirai (Tokyo, Japan), K. Furuuchi (Tokyo, Japan), K. Morimoto (Tokyo, Japan), K. Fujiwara (Tokyo, Japan), K. Nakamoto (Tokyo, Japan), Y. Tanaka (Tokyo, Japan), Y. Sasaki (Tokyo, Japan), K. Yoshimori (Tokyo, Japan), H. Ishii (Tokyo, Japan), K. Ohta (Tokyo, Japan)

Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection

Session: Clinical investigations of non-TB mycobacterial infection
Session type: Thematic Poster
Number: 2940

Disease area: Interstitial lung diseases, Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Shirai (Tokyo, Japan), K. Furuuchi (Tokyo, Japan), K. Morimoto (Tokyo, Japan), K. Fujiwara (Tokyo, Japan), K. Nakamoto (Tokyo, Japan), Y. Tanaka (Tokyo, Japan), Y. Sasaki (Tokyo, Japan), K. Yoshimori (Tokyo, Japan), H. Ishii (Tokyo, Japan), K. Ohta (Tokyo, Japan). Clinical characteristics and outcomes of patients with Mycobacterium avium complex lung disease positive for Aspergillus precipitating antibody. 2940

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Aspergillus precipitating antibody in patients with Mycobacterium avium complex lung disease; cross-sectional study Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017
Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016 Year: 2017
Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease Source: Eur Respir J 2005; 26: 1092-1096 Year: 2005
Retrospective investigation of patients positive for glycopeptidolipid-core antibody to mycobacterium avium complex pulmonary disease Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014
Characteristics and outcomes of 197 patients newly diagnosed with pulmonary mycobacterium avium complex disease Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017
Factors related to response to intermittent treatment of mycobacterium avium complex lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 557s Year: 2006
Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018
Mycobacterium avium complex infection: phenotypes and outcomes Source: Eur Respir J, 50 (3) 1701380; 10.1183/13993003.01380-2017 Year: 2017
Association between injectable aminoglycoside treatment duration and outcomes in cavitary Mycobacterium avium complex lung disease Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria Year: 2018
Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020
Clinical analysis of pulmonary Mycobacterium avium complex disease in Japan Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012
Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course Source: Eur Respir J , 49 (3) 1600537; DOI: 10.1183/13993003.00537-2016 Year: 2017
Prevalence and risk factors of frailty in patients with mycobacterium avium complex lung disease-preliminary study- Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018
Pleuroparenchymal fibroelastosis in Mycobacterium avium complex pulmonary disease: clinical characteristics and prognostic impact Source: ERJ Open Res, 7 (1) 00765-2020; 10.1183/23120541.00765-2020 Year: 2021
Clinical analysis of pulmonary Mycobacterium kansasii disease Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018
Clinical and immunological characteristics of patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019
Clinical relevance of Mycobacterium simiae in pulmonary samples Source: Eur Respir J 2008; 31: 106-109 Year: 2008
Paediatric lung transplant outcomes vary with Mycobacterium abscessus complex species Source: Eur Respir J 2013; 41: 1230-1232 Year: 2013